Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes
DNA topoisomerase I (topo I) and II (topo II) are essential enzymes that solve the topological problems of DNA by allowing DNA strands or double helices to pass through each other during cellular processes such as replication, transcription, recombination, and chromatin remodeling. Their critical roles make topoisomerases an attractive drug target against cancer. The present molecular docking study provides insights into the inhibition of topo I and II by curcumin natural derivatives. The binding modes suggested that curcumin natural derivatives docked at the site of DNA cleavage parallel to the axis of DNA base pairing. Cyclocurcumin and curcumin sulphate were predicted to be the most potent inhibitors amongst all the curcumin natural derivatives docked. The binding modes of cyclocurcumin and curcumin sulphate were similar to known inhibitors of topo I and II. Residues like Arg364, Asn722 and base A113 (when docked to topo I-DNA complex) and residues Asp479, Gln778 and base T9 (when docked to topo II-DNA complex) seem to play important role in the binding of curcumin natural derivatives at the site of DNA cleavage.
Key wordscurcumin natural derivatives DNA topoisomerases cancer drug target molecular docking polar interactions autodock
Unable to display preview. Download preview PDF.
- Kumar, A., Bora, U. 2011. In silico inhibition studies of NF-κB p50 subunit by curcumin and its natural derivatives. Med Chem Res. doi:110.1007/s00044-011-9873-0.Google Scholar